Wild Swing Trades 📈

Volume Spike After Relief Rally | Illustrative Risk/Reward Analysis Published: July 17, 2026 Quick Snapshot (as of mid-afternoon July 17): Price: ~ $7.16 – $7.28 area Today’s Move: +10–12%+ on elevated volume (~33M–37M shares vs ~20M avg) Today’s Range: ~6.32 – 7.41 Prev Close: ~6.46 Why LCID Is Moving Today LCID put in a strong momentum day with a clear volume spike after the sharp July 14 scare (intraday drop toward the 52-week low of $2.37 on bankruptcy rumor chatter). The company quickly and firmly denied the rumors, confirming sufficient liquidity well into next year. This relief rally + short-covering pressure created the type of high-volume green day that often catches attention in momentum setups. This fits the classic volume + catalyst near recent support profile many traders watch for. Short interest has remained elevated in recent reports, which can provide additional fuel on continued buying. Key Catalysts &...

LCID Momentum Setup – July 17, 2026 LCID (NASDAQ: LCID) Momentum Setup – July 17, 2026 Volume Spike After Relief Rally | Illustrative Risk/Reward Analysis Published: July 17, 2026 Quick Snapshot (as of mid-afternoon July 17): Price: \~ $7.16 – $7.28 area Today’s Move: +10–12%+ on elevated volume (\~33M–37M shares vs \~20M avg) Today’s Range: \~6.32 – 7.41 Prev Close: \~6.46 Why LCID Is Moving Today LCID put in a strong momentum day with a clear volume spike after the sharp July 14 scare (intraday drop toward the 52-week low of $2.37 on bankruptcy rumor chatter). The company quickly and firmly denied the rumors, confirming sufficient liquidity well into next year. This relief rally + short-covering pressure created the type of high-volume green day that often catches attention in momentum setups. This fits the classic volume + catalyst near recent support profile many traders watch for. Short interest has remained elevated in recent reports, which ca...

PIII Technical Analysis: Is Another Momentum Breakout Developing? Date: July 2026 P3 Health Partners (NASDAQ: PIII) has quietly moved back onto the radar after spending several sessions building a consolidation base near the $10 area. Following an overnight move approaching 9%, traders are beginning to ask whether this is simply another short-lived bounce—or the beginning of a larger momentum expansion. Quick Technical Snapshot ✔ Price is attempting to break above recent consolidation. ✔ Previous history shows explosive momentum moves. ✔ Buyers have defended support near $10. ✔ Short-term trend is improving. ✔ Momentum traders may begin watching if volume expands. Overall Technical Outlook: Moderately Bullish Trading Scenario Matrix Potential Entry Initial Target Stretch Target Potential Gain Technical Confidence* Risk $10.40-$10.60 $12.00 $13.75 13%-30% Moderate Medium $10.90-$11.05 $12.75 $15.00 15%-35% ...

PTGX: High-Probability Modest Upside + Catalyst-Driven Potential If you've been watching Protagonist Therapeutics (NASDAQ: PTGX) , you've probably noticed the stock looking perky. It closed at $135.46 on July 15, 2026 — up $4.19 (+3.19%) — sitting near its 52-week high of $141.10 after a massive run from the lows around $50. This is a classic late-stage biotech story with two major partnered assets nearing potential approval and commercialization in 2026. The setup offers a high probability of a modest near-term return (technical breakout or continued momentum) plus asymmetric upside if the catalysts hit. Company & Pipeline Overview Protagonist Therapeutics is a clinical-stage biotech using its proprietary peptide platform to develop targeted therapies for immunology/inflammation, hematology, and metabolic diseases. Icotrokinra (Icotyde) : First-in-class oral IL-23 receptor antagonist for moderate-to-severe plaque psoriasis. Partnered with Janss...

I'm Not Asking for Sympathy. I'm Asking for Understanding. Living with chronic neurological illness, bipolar disorder, and chronic pain has taught me that my abilities are not constant—they're variable. On a good day, I can solve difficult problems, build software, analyze financial markets, and tackle projects that require deep concentration. Those days are real. So are the days when a complex migraine brings one-sided head, eye, and neck pain with nausea and neurological symptoms. The days when a pain flare requires additional medication just to get through basic tasks. The days when my brain feels like it's moving through mud instead of clear air. From the outside, that inconsistency can be confusing. People naturally ask, "If you could do it yesterday, why can't you do it today?" The answer is that my conditions don't affect me the same way every day. They fluctuate. Some days I hav...

⚠️ Important Disclaimer: This is NOT financial advice . SOAR is a high-risk microcap stock. Microcap stocks can be extremely volatile, illiquid, subject to dilution, reverse splits, and can go to zero. The information below is for educational and illustrative purposes only. Past performance and historical setups do not predict future results. Always do your own research, use proper risk management, and never risk more than you can afford to lose. Consult a licensed financial advisor if needed. SOAR (Volato Group) – Illustrative Swing Trade Scenarios Current price area: \~ 0.148 . These are example setups based on recent price action, volume, key levels, and upcoming catalysts (earnings mid-to-late August). View SOAR chart on TradingView → Scenario Entry Zone Stop Loss Target 1 (Scale Out) Target 2 (Runner) Est. Gain (T1 / T2) Est. Prob. (T1) ...

Navigating the Shift: Creatively Blazing Pathways Lately, I’ve been looking closely at the hurdles so many people are hitting right now. The reality is that the traditional playbooks for a stable life—securing predictable housing, climbing a standard career ladder, or relying on a single steady paycheck—are failing people in real time. The housing market has become a high-stakes pressure cooker, the job market rewards rapid agility over long-term loyalty, and the margin for error has shrunk to almost zero. Everybody is struggling to adjust to a landscape where the old maps no longer match the terrain. But out of sheer necessity comes an incredible wave of resourcefulness. People are adapting. They are finding alternatives, cutting overhead down to the bone, and building independent, highly portable lives designed to survive economic shocks. Moving forward, I'm going to be dedicating a series of upcoming posts on this blog to documenting those exact tactics. I’m ...

High-Velocity Swing Trading Watchlist: AI Momentum, Semiconductor Breakouts & Low-Float Runners The goal of this watchlist is identifying high-velocity swing opportunities : stocks with the potential for rapid 20%, 50%, or even 100%+ moves when momentum, catalysts, volume, and technical structure align. This approach prioritizes probability + asymmetric reward rather than trying to perfectly catch bottoms or tops. The focus is on: Relative strength versus sector peers Volume expansion and breakout confirmation Catalyst-driven momentum Support reloads and continuation patterns Tight invalidation levels High reward-to-risk setups Risk Disclaimer This article is for educational and research purposes only and is not financial advice. Momentum and micro-cap trading carry substantial risk. Stocks discussed may experience extreme volatility, dilution, failed breakouts, or rapid reversals. Always verify current price, float, news, filings, liquidity, and tec...

🚀 High-Velocity Swing Setups — July 2026 High-probability momentum & breakout plays with velocity (quick 20-100%+ potential) drawn from trusted trader sources and creative cross-checks. Focused on volume/catalyst near support, tight stops, and asymmetric reward-to-risk. ⚠️ CRITICAL DISCLAIMER — READ BEFORE TRADING This post is for educational and informational purposes only and does NOT constitute financial, investment, trading, or tax advice. Trading equities — especially momentum names, semis, and microcaps — carries substantial risk of loss, including total loss of capital. Past performance is never indicative of future results. Markets are volatile and can move against you rapidly. Always do your own research (DYOR). Verify every level, catalyst, and price on live charts (TradingView, Finviz, your broker). Use proper risk management: risk no more than 0.5–1% of your account per trade, employ hard stops, and size positions appropriately for your...